Cassava Sciences Inc vs Ferrari NV — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Ferrari NV trades at $405.57 (market cap $71.67B). The key difference: Ferrari NV is far larger — about 1500.9× Cassava Sciences Inc's market cap, and Ferrari NV pays a 1.04% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | RACE | |
|---|---|---|
Market Cap | $47.75M | $71.67B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.64 | $504.09 |
52-Week Low | $0.87 | $314.63 |
Enterprise Value | -$34.93M | $73.60B |
Dividend Yield | — | 1.04% |
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →